Strata Critical Medical, Inc. (SRTA)
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-11-04
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-11-04
QuarterlyIQ Insights · SRTA
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -55.1% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 298 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 13.9% |
Growth built into the price is above our model estimate.
The price assumes 69.0 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name has been missing across recent quarters and missed its most recent quarter. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 13 industry peers · Company calendar date is not available
SRTA — earnings miss
Dated 2026-11-03
Results of Operations and Financial Condition. On November 3, 2026, Strata Critical Medical, Inc. (“Strata”) issued a press release announcing its financial results for the third quarter ended September 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. This information is intended to be furnished under
Why it matters: The Q3 report can show whether recent growth supports the higher full-year revenue range.
Supportive ifOn November 3, management keeps the $285–295 million 2026 revenue range and reports Q3 revenue growth from Q2’s $72.5 million.
Worry ifOn November 3, management cuts the 2026 revenue range or reports Q3 revenue below Q2’s $72.5 million.
Why it matters: Clinical growth can show whether new services and deals are adding to the business.
Supportive ifQ3 clinical revenue rises above Q2’s $24.3 million. Management reports growth from services added through the Q2 deals.
Worry ifQ3 clinical revenue falls below Q2’s $24.3 million. Or, management says acquired services added no revenue.
Why it matters: Higher profit per dollar of sales would support the company’s raised profit goal.
Supportive ifThe November 3 report keeps 2026 adjusted EBITDA guidance at $33–35 million. Q3 adjusted EBITDA is above Q2’s $7.9 million.
Worry ifThe November 3 report cuts 2026 adjusted EBITDA guidance. Or, it shows Q3 adjusted EBITDA below Q2’s $7.9 million.
Why it matters: Cash flow shows whether earnings turn into cash after working capital and aircraft costs.
Supportive ifThe November 3 report keeps the $15–22 million full-year free cash flow goal and reports Q3 free cash flow above Q2’s $2.9 million.
Worry ifThe November 3 report cuts the $15–22 million goal or reports Q3 free cash flow below Q2’s $2.9 million.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$168 on $10,000 · ±1.7% | How much price usually moves either way. |
| Bad day | $464 loss on $10,000 · 4.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,385 loss on $10,000 · 33.9% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.